The Sugira Muryango Longitudinal & Spillover Study

February 10, 2023 updated by: Theresa Betancourt, Boston College

Understanding Longer-term Effects of a Father-engaged, Play-based Home Visiting Intervention to Promote Early Childhood Development and Prevent Violence in Rwanda: The Sugira Muryango Longitudinal & Spillover Study

The Early Childhood version of Sugira Muryango is a family-based, home-visiting intervention targeted at early childhood development and implemented with families living in extreme poverty in three districts of Rwanda. This version of Sugira Muryango was first tested in two small pilot studies and a large cluster randomized trial (CRT) was implemented between February 2018 and September 2019 . Pre- to post-intervention findings demonstrated that Sugira Muryango led to improvements in caregiver behaviors linked to child development and health as well as reductions in violence, which were sustained 12 months after the intervention, at which time improvements in child development were observed.

The Research Program on Children and Adversity in the Boston College School of Social Work is led by Dr. Theresa S. Betancourt and will, in partnership with the University of Rwanda, FXB-Rwanda and Laterite, conduct a longitudinal follow-up study to investigate the longer-term outcomes of the Sugira Muryango intervention in families who participated in the CRT. The four-year follow-up will examine the long-term and sustained outcomes of the intervention. In particular, the investigators will look at key indicators of long-term positive outcomes for children such as school readiness and transition to formal schooling. Given the lack of longitudinal research on intervention programs supporting ECD in sub-Saharan Africa, this study will contribute greatly to the body of knowledge on the costs and benefits of investments in ECD and guide policy makers and government leaders on making impactful investments in children, leading to long-term benefits for the population at large.

The follow-up study involves two activities:

Activity A: Pilot to assess measures performance of newly added measures and field test study protocols.

Activity B: Four-year follow-up of families who participated in the CRT of the Sugira Muryango intervention.

Study Overview

Detailed Description

The aim of the study is to assess the impacts of Sugira Muryango on treated families compared to families receiving only usual care (controls) four years after the intervention. Moreover, at this visit, the investigators will also for the first time examine potential spillover effects of Sugira Muryango onto siblings of children enrolled in the original study. The longitudinal follow-up study will assess whether and to what extent Sugira Muryango has an impact on caregivers' awareness and utilization of available services; support for children's education and playful learning; home hygiene; parenting practices, including child feeding/nutrition, stimulation and sensitive care; experiences of intimate partner violence; use of harsh discipline; mental health, including depression and alcohol use; gender attitudes; and overall wellbeing. It will also assess whether and to what extent Sugira Muryango has an impact on children's physical development; cognitive and linguistic development; temperament; enrollment in early or formal education; school readiness, including self-regulation and early literacy and numeracy; mental health, including internalizing and externalizing and depression; behavior, including conduct problems; and gender attitudes. Finally, the study will assess potential covariates such as the impact of the COVID-19 pandemic and associated lockdowns, child disability, and household size and composition.

The specific objectives are:

To assess the long-term (4 years post-intervention) impact of Sugira Muryango on caregiver behaviors, attitudes, mental health and wellbeing, especially as related to parenting and intimate partner violence.

To assess the long-term (4 years post-intervention) impact of Sugira Muryango on previously enrolled children's physical and cognitive development and health.

To assess the long-term (4 years post-intervention) impact of Sugira Muryango on previously enrolled children's behavior, mental health, school readiness and gender attitudes.

To assess the long-term (4 years post-intervention) impact of Sugira Muryango on younger and older siblings of children enrolled in the intervention, including on their physical and cognitive development and health, and in the case of older siblings their school readiness, behavior and gender attitudes.

The following activities will be conducted during the proposed 4-year follow up study:

  • Activity A: Pilot to assess measures performance and field test study protocols.

    • Phase A1: Translation and adaptation of newly selected measures.
    • Phase A2: A Pilot study of selected new child measures with 150 children and their primary caregivers in a sector of the Sugira Muryango PLAY Collaborative Expansion Study to test the feasibility and validity of new tools.
  • Activity B: Four-year follow-up of families who participated in the Cluster Randomized Trial (CRT) of the Sugira Muryango intervention.

    • Phase B1: Household tracking and re-enrollment of 1,049 households that participated in the prior CRT (April-May 2022).
    • Phase B2: Quantitative (full sample) and qualitative (subsample) data collection with the 1,049 households from the prior CRT, including children and caregivers who were in the original CRT, and siblings in a subset of households to test for spillover effects (June [Quantitative] & December [Qualitative] 2022).

Our specific hypotheses are as follows:

Longitudinal Hypotheses

  1. Sugira Muryango will have effects (superior when compared to usual care households) on a range of outcome domains, both new domains and those assessed in the prior CRT.

    1. Sugira Muryango will continue to have effects among eligible caregivers and children compared to controls on a range of outcomes assessed at previous waves of data collection, and
    2. Sugira Muryango will have effects on new outcomes that have become relevant as the children have aged, including aspects of school readiness.

    Spillover Hypothesis

  2. Sugira Muryango will have positive effects on younger and older siblings of children who were eligible for and participated in the intervention compared to siblings in usual care households.

Secondary exploratory analyses Analyses evaluating potential child and caregiver sex differences will be performed across all outcomes to examine differences in parenting behaviors and child outcomes as children get older and approach school age.

Study benefits and justification Potential societal benefits of the study include increased knowledge about evaluating ECD and parenting in Rwanda, increased knowledge of ECD in Rwanda, and increased knowledge regarding family-based ECD interventions to improve child development outcomes in low-resource settings. Intervening in early childhood has been demonstrated to be highly cost-effective for improving child development and life outcomes, yet interventions in low-resource settings-particularly in sub-Saharan Africa-are limited and not always well-evaluated or systematically implemented. At the individual level, families who participate in the study will receive free disability and behavioral screening for eligible children and will be connected with support services should a disability or other risk of harm be identified.

The key research question is whether Sugira Muryango provides lasting benefits to children in households that received the intervention. Little longitudinal research into home-visiting ECD interventions in this region exists; findings from the proposed research will add critical evidence to inform Rwanda's expansion of ECD support to families as well as learnings for other countries.

The study has been reviewed and approved by the Rwanda National Ethics Committee, the National Institute of Statistics of Rwanda, and the National Council for Science and Technology in Rwanda.

Study Type

Observational

Enrollment (Actual)

2932

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ngoma, Rwanda
        • Homes and community buildings
      • Nyanza, Rwanda
        • Homes and community buildings
      • Rubavu, Rwanda
        • Homes and community buildings

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 months and older (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

The population consists of families who participated in the earlier CRT. Families for the CRT were randomly selected from government-provided lists of families who were eligible for the Vision Umurenge Program (VUP). Families' participation in the VUP and selection into one of two versions of the VUP program, namely classic public works (cPW) or expanded public works (ePW), was determined by governmental policies and was not under the control of the research team. Eligibility for VUP indicates that the family was in the poorest category under Rwanda's poverty categorization system (Ubudehe 1). Families were living in Ngoma, Nyanza or Rubavu district of Rwanda and had at least one child between the ages of 6-36 months.

Description

Participated in the Sugira Muryango CRT in 2018-19 (Trial Registration Number NCT02510313).

Family inclusion criteria for the CRT were:

  • living in the Rubavu, Ngoma or Nyanza District of Rwanda
  • being VUP-eligible (according to the Rwandan government)
  • having at least one child aged 6-36 months living in the home
  • having at least one caregiver who was willing to discuss and enhance their caregiving practices by interacting with a home-visiting coach (a community-based volunteer or CBV).

Further caregiver inclusion criteria were:

  • was aged 18 or older and cared for child(ren)
  • lived in the same household as the child(ren). For the current Longitudinal Study, inclusion criteria for families are
  • having participated in the prior CRT
  • living in Ngoma, Nyanza, or Rubavu districts
  • having at least one child who participated in the CRT and who is currently living in the household.

Inclusion criteria for younger siblings are:

  • aged 3 months or older
  • was not eligible to participate in the original CRT due to age (below 6 months or not yet born at the time of CRT).

Inclusion criteria for older siblings are:

  • aged 12 years or younger
  • lived in the household but was not eligible to participate in the original CRT due to age (above 36 months at the time of CRT)
  • currently lives in the household that participated in the CRT.

Exclusion Criteria:

Other than not meeting inclusion criteria, specific family exclusion criteria for the CRT were:

  • caregiver(s) having severe cognitive impairments which precluded their ability to speak to the research questions under study
  • families or caregivers being in the midst of crisis (e.g., a caregiver(s) with active suicidal attempts or psychosis). Families with ongoing crises or disabilities were excluded from the study and were referred to appropriate services.
  • These exclusion criteria remain the same for the current Longitudinal study.
  • Siblings will be excluded from sampling for the spillover study if the primary caregiver has been away from the household for six months or more.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Treatment group
Families in the treatment group received one welcome visit, 12 visits from a community-based volunteer trained in the Sugira Muryango intervention over 3-4 months, as well as booster visits at 3 and 6 months. The primary caregiver, secondary caregiver if applicable, and any children ages 6-36 months participated in the sessions. Other family members were welcome to join as available.
Control group
Usual childcare (no intervention)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
"Home Observation Measurement of the Environment" infants/toddlers survey and early childhood survey
Time Frame: Through study completion (4 years)
Observation of caregiver engagement and stimulation of children (younger siblings and CRT children)
Through study completion (4 years)
"Ages & Stages Questionnaire - 3"
Time Frame: Through study completion (4 years)
Caregiver report on child's development (younger siblings)
Through study completion (4 years)
"Mullen Scale of Early Learning"
Time Frame: Through study completion (4 years)
Observation of child's cognitive, motor, and linguistic development (younger siblings)
Through study completion (4 years)
"Kaufman Assessment Battery for Children-2"
Time Frame: Through study completion (4 years)
Observation of child's cognitive and linguistic development (CRT children and older siblings)
Through study completion (4 years)
"Wechsler Preschool & Primary Scale of Intelligence"
Time Frame: Through study completion (4 years)
Observation of child's cognitive and linguistic development
Through study completion (4 years)
"International Development & Early Learning Assessment" stimulating care and play module
Time Frame: Through study completion (4 years)
Caregiver report on playful parenting activities and childcare arrangement (for all children)
Through study completion (4 years)
"Multiple Indicator Cluster Survey" child discipline module
Time Frame: Through study completion (4 years)
Caregiver self-report of child discipline practices and behaviors (for all children)
Through study completion (4 years)
Combined module based on "Multiple Indicator Cluster Survey" and "ISPCAN Child Abuse Screening Tool"
Time Frame: Through study completion (4 years)
Child self-report of experiences of discipline and violence (older siblings)
Through study completion (4 years)
DHS "Intimate Partner Violence" survey
Time Frame: Through study completion (4 years)
Caregiver self-report on victimization and perpetration of intimate partner violence
Through study completion (4 years)
"Child Behavior Checklist"
Time Frame: Through study completion (4 years)
Caregiver report on child's internalizing and/or externalizing (CRT children and older siblings)
Through study completion (4 years)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
"Observation of Mother-Child Interactions"
Time Frame: Through study completion (4 years)
Observation of caregiver's sensitive care (younger siblings)
Through study completion (4 years)
"The Role of Play in Children's Learning"
Time Frame: Through study completion (4 years)
Caregiver self-report on play for children's learning and development
Through study completion (4 years)
"Parental Acceptance-Rejection Questionnaire"
Time Frame: Through study completion (4 years)
Caregiver self-report of stimulating care and play
Through study completion (4 years)
DHS/Promundo "Father Engagement & Financial Decision-Making" survey
Time Frame: Through study completion (4 years)
Caregiver self-report of financial decision making and father engagement in the family
Through study completion (4 years)
"Gender Equitable Men" scale
Time Frame: Through study completion (4 years)
Caregiver self-report of views of gender and masculinity
Through study completion (4 years)
"Multiple Indicator Cluster Survey (5)" WASH module
Time Frame: Through study completion (4 years)
Caregiver self-report of home sanitation & hygiene
Through study completion (4 years)
World Health Organization "Infant and Young Child Feeding Practices" survey
Time Frame: Through study completion (4 years)
Caregiver self-report of feeding practices
Through study completion (4 years)
"Hopkins Symptom Checklist (25)"
Time Frame: Through study completion (4 years)
Diagnostic tool for depression and anxiety in caregivers
Through study completion (4 years)
"Enrollment in early education" survey
Time Frame: Through study completion (4 years)
Caregiver report of child's enrollment in early education
Through study completion (4 years)
"Child Enrollment in Formal Education" survey
Time Frame: Through study completion (4 years)
Caregiver report of child's enrollment in formal education
Through study completion (4 years)
"Service utilization" survey
Time Frame: Through study completion (4 years)
Caregiver self-report on services utilized, e.g. government and non-governmental inputs and services
Through study completion (4 years)
Anthropometric measures: height in centimeters
Time Frame: Through study completion (4 years)
Measure of child height in centimeters (younger siblings and CRT children)
Through study completion (4 years)
"Preschool Self-Regulation Assessment"
Time Frame: Through study completion (4 years)
Caregiver report of child's self-regulation (CRT children)
Through study completion (4 years)
"Infant Behavior Questionnaire"
Time Frame: Through study completion (4 years)
Caregiver report of child's temperament (younger siblings)
Through study completion (4 years)
"Early Childhood Behavior Questionnaire"
Time Frame: Through study completion (4 years)
Caregiver report of child's temperament (younger siblings)
Through study completion (4 years)
"Early Grade Reading Assessment"
Time Frame: Through study completion (4 years)
Assessment of early literacy skills in children (older siblings)
Through study completion (4 years)
"Center for Epidemiological Studies Depression Scale"
Time Frame: Through study completion (4 years)
Diagnostic tool for depression in children (older siblings)
Through study completion (4 years)
"Gender Equitable Men" scale
Time Frame: Through study completion (4 years)
Child self-report of views of gender and masculinity (older siblings)
Through study completion (4 years)
Anthropometric measures: weight in kilograms
Time Frame: Through study completion (4 years)
Measure of child weight in kilograms (younger siblings and CRT children)
Through study completion (4 years)
Anthropometric measures: standardized height-for-weight
Time Frame: Through study completion (4 years)
Height and weight will be combined and the resulting scores standardized and reported as z-scores (younger siblings and CRT children)
Through study completion (4 years)
Anthropometric measures: standardized height-for-age
Time Frame: Through study completion (4 years)
Height and age will be combined and the resulting scores standardized and reported as z-scores (younger siblings and CRT children)
Through study completion (4 years)
Anthropometric measures: middle upper arm circumference in centimeters
Time Frame: Through study completion (4 years)
Measure of child circumference of middle upper arm in centimeters (younger siblings and CRT children)
Through study completion (4 years)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
"International Development & Early Learning Assessment" parent attitudes module
Time Frame: Through study completion (4 years)
Caregiver self-report of attitudes towards children's education
Through study completion (4 years)
"International Development & Early Learning Assessment" parent expectations module
Time Frame: Through study completion (4 years)
Caregiver self-report of expectations towards children's education
Through study completion (4 years)
Epstein survey
Time Frame: Through study completion (4 years)
Caregiver self-report of support for children's education
Through study completion (4 years)
World Health Organization "Alcohol Use Disorders Identification Test (AUDIT)"
Time Frame: Through study completion (4 years)
Caregiver self-report of alcohol use and/or abuse
Through study completion (4 years)
"Flourishing Scale"
Time Frame: Through study completion (4 years)
Caregiver self-report on quality of life
Through study completion (4 years)
"Gender Equitable Men" norms scale
Time Frame: Through study completion (4 years)
Caregiver self-report of perceived norms related to gender and masculinity
Through study completion (4 years)
"Youth Conduct Problems Scale - Rwanda"
Time Frame: Through study completion (4 years)
Child self-report of conduct problems (older siblings)
Through study completion (4 years)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

April 20, 2022

Primary Completion (ACTUAL)

June 30, 2022

Study Completion (ACTUAL)

December 31, 2022

Study Registration Dates

First Submitted

May 27, 2022

First Submitted That Met QC Criteria

June 1, 2022

First Posted (ACTUAL)

June 6, 2022

Study Record Updates

Last Update Posted (ACTUAL)

February 13, 2023

Last Update Submitted That Met QC Criteria

February 10, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 22.198.01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

3
Subscribe